Home / Inspections / 1181540

FDA Inspection 1181540 — Shore Institute For Reproductive Medicine, P.C.

Shore Institute For Reproductive Medicine, P.C. — FEI 3003945094

The FDA completed an inspection of Shore Institute For Reproductive Medicine, P.C. on October 13, 2022 in Lakewood, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 13, 2022
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lakewood, NJ (United States)

Facility

Other inspections at this facility

  • 1323506 (NAI Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1108884 (NAI Thu Oct 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1030558 (NAI Fri Oct 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 947439 (NAI Wed Nov 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 882856 (NAI Wed Jun 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources